InsidersTradesSigma
基于 3 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the detailed record of transactions filed by Hamill John P., 首席财务官. Director active across 2 companies, notably Windtree Therapeutics INC. In total, 12 disclosures have been published. Breakdown: 6 buys · 0 sell. Total volume traded: €18k. Activity tracked since 4 March 2022. The latest transaction was filed on 12 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 条申报中的 12 条
Hamill John P. is Chief Financial Officer. He has 12 filings in total. Among the sampled recent filings, they cover the period from 2022-03-07 to 2026-03-16, with attribution transactions and buys for EUR 18259, and no sales.